Takeda Pharmaceutical (TAK) EBT (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly EBT of $1.0 billion for Q2 2026, down 1.93% year-over-year from $1.0 billion in Q2 2025, and down 1.6% quarter-over-quarter from $1.0 billion in Q1 2026.
Takeda Pharmaceutical (TAK) EBT (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's EBT history runs 10 years deep, the most recent figure standing at $1.0 billion for Q2 2026.
- In Q2 2026, EBT fell 1.93% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.2 billion (down 61.94% YoY), while the FY2026 annual figure was -$945.7 million, down 182.28% from the prior year.
- EBT for Q2 2026 stood at $1.0 billion, down from $1.0 billion in the prior quarter.
- The five-year high for EBT was $2.3 billion in Q3 2023, with the low at -$3.0 billion in Q4 2025.
- The 5-year median for EBT is $1.0 billion (2025), against an average of $852.0 million.
- The sharpest annual moves came in 2023 and 2025: EBT jumped 384.77% in 2023, then sank 318.9% in 2025.
- Takeda Pharmaceutical's EBT stood at $758.5 million in 2022, then tumbled by 57.27% to $324.1 million in 2023, then slumped by 317.8% to -$705.8 million in 2024, then tumbled by 318.9% to -$3.0 billion in 2025, then soared by 134.53% to $1.0 billion in 2026.
- Business Quant data shows TAK's EBT at $1.0 billion in Q2 2026, $1.0 billion in Q1 2026, and -$3.0 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | -2.96 Bn |
| Sep 30, 2025 | 2.12 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 987.12 Mn |
| Dec 31, 2024 | -705.80 Mn |
| Sep 30, 2024 | 1.89 Bn |
| Jun 30, 2024 | 877.53 Mn |
| Mar 31, 2024 | 921.75 Mn |
| Dec 31, 2023 | 324.05 Mn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 985.33 Mn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 758.46 Mn |
| Sep 30, 2022 | 467.37 Mn |
| Jun 30, 2022 | 1.20 Bn |
| Mar 31, 2022 | 1.92 Bn |
| Dec 31, 2021 | 635.10 Mn |
| Sep 30, 2021 | 558.18 Mn |